TTI2 Antikörper (AA 159-264)
-
- Target Alle TTI2 Antikörper anzeigen
- TTI2 (TELO2 Interacting Protein 2 (TTI2))
-
Bindungsspezifität
- AA 159-264
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TTI2 Antikörper ist unkonjugiert
- Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Ratte
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human TELO2-interacting protein 2 protein (159-264AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TTI2 (TELO2 Interacting Protein 2 (TTI2))
- Andere Bezeichnung
- TTI2 (TTI2 Produkte)
- Synonyme
- C8orf41 antikoerper, TELO2 interacting protein 2 antikoerper, TTI2 antikoerper, Tti2 antikoerper
- Hintergrund
-
Background: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs.
Aliases: C8orf41 antibody, CH041_HUMAN antibody, TELO2 interacting protein 2provided antibody, TTI2 antibody, Uncharacterized protein C8orf41 antibody
- UniProt
- Q6NXR4
-